Year: 2019

Japanese shares slipped on Wednesday after a keenly awaited speech from U.S. President Donald Trump disappointed investors, offering few details on progress in trade talks with China. Trump on Tuesday dangled the prospect of completing an initial trade deal with China “soon”, but at the same time warned he would raise tariffs on Chinese goods “very substantially” if China does not strike a deal.. “I guess it was his usual tactics but it wasn’t positive,” said Hideyuki Ishiguro, senior strategist at Daiwa Securities. …read more […]

Japan Display reported on Wednesday an 11th consecutive quarterly net loss on sluggish display sales and restructuring costs as the cash-strapped company scrambles to clinch a bailout deal with Apple Inc and other investors. The liquid crystal display (LCD) maker for smartphones, which gets more than half of its revenue from Apple, posted a net loss of 25.4 billion yen ($233 million) in the July-September quarter, wider than the 7.8 billion loss a year earlier. Japan Display, money-losing for the past five years due to slowing Apple iPhone sales and the delayed adoption of organic light-emitting diode (OLED) …read more […]

Legendary fund manager Li Lu (who Charlie Munger backed) once said, ‘The biggest investment risk is not the volatility… …read more […]

Asian stocks and Wall Street futures fell on Wednesday, as confusing signals over the extent of progress made in U.S.-China trade talks and concern about intensifying unrest in Hong Kong hurt demand for risky assets. Hong Kong shares slumped 2% to a four-week low, battered by fears that anti-government protests appear to be spiralling out of control. The dollar drifted in Asia after U.S. President Donald Trump said a trade deal was “close” but gave no new details on when or where an agreement would be signed, disappointing investors in what was billed as a major speech on …read more […]

TORONTO/MONTREAL, Nov 13 (Reuters) – Johnson & Johnson’s Remicade, a blockbuster drug that treats autoimmune disorders, has steadily lost market share among patients enrolled in the Canadian province of Quebec’s public drug program, even after a court ruling reinstated full coverage in January, a Reuters analysis of government data shows. The plan’s administrator stopped covering Remicade, J&J unit Janssen’s version of the drug infliximab, for some new patients in February 2017, in favor of cheap near-copies called biosimilars, mainly Pfizer Inc’s version of infliximab, called Inflectra. …read more […]

The burgeoning lithium industry, which produces the powerhouse metal used to make electric vehicle (EV) batteries, has entered its first major downturn, an unwelcome bruising for investors eager to help combat climate change. Albemarle Corp, Tianqi Lithium Corp and others have been producing more lithium than automakers need. “Current market conditions are challenging,” Luke Kissam, Albemarle’s chief executive officer, said last week. …read more […]

(Bloomberg) — Dairy Farmers of America Inc, the biggest U.S. dairy cooperative, is in advanced talks to acquire U.S. milk processor Dean Foods Co. But other would-be buyers could emerge.While discussions are taking place between DFA and Dean, no agreement has been reached for the purchase of all or some of the Dallas-based company’s assets, Monica Massey, executive vice president and chief of staff at DFA, said in an emailed response to questions. She didn’t speculate on prospective bidders.A deal could be a lengthy process, including an antitrust review. Any transaction would require an “extensive review of Dean Foods’ assets, …read more […]

Q3 2019 Continental AG Earnings Call …read more […]

“We are happy to cooperate with any questions about the project,” Google said in a blog post later on Tuesday, regarding the federal inquiry. The Office for Civil Rights in the Department of Health and Human Services will look into the data collection to ensure the partnership is in compliance with the Health Insurance Portability and Accountability Act (HIPAA) which safeguards medical information, the Journal said. …read more […]

Q3 2019 Nektar Therapeutics Earnings Call …read more […]

Asian stocks and Wall Street futures fell on Wednesday, as growing worries that U.S.-China trade talks are stalling and concern about intensifying unrest in Hong Kong hurt demand for risky assets. Hong Kong shares slumped 1.8% to a two-week low, battered by fears that anti-government protests appear to be spiralling out of control. The dollar drifted in Asia after U.S. President Donald Trump said a trade deal was “close” but gave no new details on when or where an agreement would be signed, disappointing investors in what was billed as a major speech on his administration’s economic …read more […]

(Bloomberg) — Chesapeake Energy Corp., the U.S. natural gas producer that’s struggling under the burden of a high debt-load and low prices, said its second-biggest investor distributed its stake to its limited partners.NGP Energy Capital Management LLC “made an in kind pro rata distribution of the shares” to partners of its funds, Oklahoma City-based Chesapeake said in a statement late Tuesday. The statement made no further clarification, and calls and messages to Chesapeake and NGP after normal business hours weren’t immediately returned.NGP held a 16% stake with a market value of $208.2 million. The private equity firm became a major …read more […]

Q3 2019 Green Plains Inc and Green Plains Partners LP Earnings Call …read more […]